Tempus And Recursion Extend Existing Data License Agreement And Enter New License Agreement For Recursion’S RNA Foundation Model

By Reuters News

- Recursion Pharmaceuticals, Inc. RXRX.O:

  • TEMPUS AND RECURSION EXTEND EXISTING DATA LICENSE AGREEMENT AND ENTER NEW LICENSE AGREEMENT FOR RECURSION’S RNA FOUNDATION MODEL

  • TEMPUS AI, -CO AND RECURSION EXTEND DATA PARTNERSHIP THROUGH NOVEMBER 2029

  • TEMPUS AI, - RECURSION GRANTS TEMPUS NON-EXCLUSIVE WORLDWIDE LICENSE TO RNA SEQUENCING MODEL TXFM

Further company coverage: RXRX.O

Capital Com is an execution-only service provider. The present material must be regarded as marketing communication and should not be interpreted as investment research or investment advice. Any opinion that may be provided on this page does not constitute a recommendation by Capital Com or its agents. We do not make any representations or warranty on the accuracy or completeness of the information that is provided on this page. If you rely on the information on this page, then you do so entirely at your own risk